Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1991
10/19/1991CA2040605A1 (s)-alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereof
10/19/1991CA2040604A1 Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide
10/19/1991CA2040236A1 Poly (.alpha.-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
10/19/1991CA2039566A1 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
10/19/1991CA2039063A1 Hypophosphite-containing cotelomers as antitartar agents
10/19/1991CA2037015A1 L-glutamic acid derivatives
10/18/1991WO1991016306A1 An improved process for the preparation of substituted indolone derivatives
10/18/1991WO1991016047A1 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents
10/18/1991CA2078772A1 4-(oxygen, sulfur or nitrogen substituted) -methyl 5-hydroxy-2 (5h) - furanones as anti-inflammatory agents
10/18/1991CA2078770A1 2(5h)-furanones substituted in the 3 position, as ca2+ channel antagonists and anti-inflammatory agents
10/18/1991CA2040471A1 Controlled release drug formulation
10/18/1991CA2035155A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/18/1991CA2031994A1 Injectable formulations containing the sodium salt of naproxen
10/17/1991WO1991016305A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991WO1991015580A1 Gene therapy for cell proliferative diseases
10/17/1991WO1991015500A1 Oligonucleotide analogs
10/17/1991WO1991015485A1 Novel pyridine esters
10/17/1991WO1991015479A1 Substituted pyrazoles, isoxazoles and isothiazoles
10/17/1991WO1991015475A1 Novel vitamin d analogues
10/17/1991WO1991015468A1 Novel compound
10/17/1991WO1991015463A1 PROCESS FOR PREPARING EQUIMOLAR SALTS OF A DICARBOXYLIC α-AMINO ACID AND A DIVALENT METAL, MAGNESIUM ASPARTATE SALT OBTAINED BY SAID PROCESS AND ITS APPLICATIONS
10/17/1991WO1991015241A1 Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
10/17/1991WO1991015233A1 Use of protease nexin-i to mediate wound healing
10/17/1991WO1991015217A1 Anticoagulant oligosaccharides
10/17/1991WO1991015216A1 Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
10/17/1991WO1991015215A1 Fluid resuscitation
10/17/1991WO1991015214A1 Medicament for treating hyperlipidaemia and/or atherosclerosis
10/17/1991WO1991015213A1 Side-chain hydroxylated cholesterol derivatives, agents for dissolution of cholesterol gallstones
10/17/1991WO1991015212A1 Antiviral compositions and method for their use
10/17/1991WO1991015211A1 Veterinary compositions
10/17/1991WO1991015210A1 Compositions comprising cytotoxic agent and permeation enhancers
10/17/1991WO1991015208A1 Veterinary treatment
10/17/1991WO1991015206A1 Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
10/17/1991WO1991015204A2 METHOD AND AGENTS FOR THE SELECTIVE REDUCTION OF Lp(a)
10/17/1991WO1991015202A1 Pharmaceutical aqueous solution of 4-[2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid
10/17/1991WO1991015201A1 Method of treating diseases associated with elevated levels of interleukin 1
10/17/1991WO1991015200A2 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
10/17/1991WO1991015189A1 Method and composition for prevention of stomatitis in denture users
10/17/1991WO1991015176A1 Device and method for enhanced administration of physostigmine
10/17/1991WO1991015124A1 Modulator agent and use thereof
10/17/1991WO1991013062A3 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
10/17/1991WO1991006537A3 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
10/17/1991DE4011543A1 Agent to assist giving up smoking - comprises non-poisonous water-soluble silver salt, mixed with or suspended or embedded in suitable carrier
10/17/1991CA2084073A1 Fluid resuscitation
10/17/1991CA2080582A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991CA2079903A1 Gene therapy for cell proliferative diseases
10/17/1991CA2079803A1 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
10/17/1991CA2079783A1 Use of protease nexin-i to mediate wound healing
10/17/1991CA2079343A1 Substituted pyrazoles, isoxazoles and isothiazoles
10/17/1991CA2063588A1 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis
10/17/1991CA2039921A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
10/17/1991CA2029857A1 Sustained-release preparation composition comprising pyridazinone compound
10/16/1991EP0452273A1 Combination of formate esters and pepper-like constituents as an orally-consumable chloroform substitute
10/16/1991EP0452268A2 Substained release of active agents from bioadhesive microcapsules
10/16/1991EP0452264A1 Hydroxylamine compounds
10/16/1991EP0452210A1 Pharmaceutical and/or dietetic compositions containing carnitine, lysine and methionine with or without pantothenic acid
10/16/1991EP0452204A1 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them
10/16/1991EP0452179A2 Polymer-combined drug for gastric treatment and a method for producing the drug
10/16/1991EP0452170A1 1,2,5,6-Tetrahydropyridin-3-carboxaldehyde oxime derivatives, process for their preparation and their use as drugs
10/16/1991EP0452145A2 Coated composition and its preparation process
10/16/1991EP0452107A1 Pyrimidinedione derivatives and antiarrythmic agents containing same
10/16/1991EP0452101A2 Spiro bridged and unbridged heterocyclic compounds
10/16/1991EP0452076A1 Thiazole and imidazole derivatives and antiulcer composition containing same
10/16/1991EP0452074A2 Ergoline-8-carboxamides for blocking 5HT receptors
10/16/1991EP0452040A2 Polysaccharide compounds produced by fermentation
10/16/1991EP0451965A1 Processes and intermediates for the preparation of 5-oxygenated HMG-COA reductase inhibitors
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451873A1 Derivatives of 2,2-dimethyl cyclopropanecarboxylic acid substituted at c-3 by a saturated halogenated chain, process for their preparation and their use in the synthesis of pesticidal products
10/16/1991EP0451869A2 Use of steroid derivatives in the treatment of endometriosis
10/16/1991EP0451836A2 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
10/16/1991EP0451835A1 Intermediates for difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
10/16/1991EP0451834A2 Alpha-mannosidase and fucosidase inhibitors
10/16/1991EP0451790A1 3,5-disubstituted 2-isoxazolines and isoxazoles, process for their preparation, medicines containing them and their use
10/16/1991EP0451764A1 Carbapenem compounds
10/16/1991EP0451760A1 Nitrato alkanoic acid derivatives and method for their production
10/16/1991EP0451753A1 In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines
10/16/1991EP0451750A2 Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients
10/16/1991EP0451654A2 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation
10/16/1991EP0451634A2 Cycloalkano[b]dihydroindoles and -indolesulphonamides substituted by heterocycles
10/16/1991EP0451626A2 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids
10/16/1991EP0451547A1 1,4,8-Triazacyclotridecane derivatives having prolyl endopeptidase inhibiting activity
10/16/1991EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders
10/16/1991EP0451486A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T
10/16/1991EP0451484A1 Deprenyl/L-dopa/carbidopa pharmaceutical composition
10/16/1991EP0451436A2 Method of curing and preventing obesity by alpha-amylase inhibitor
10/16/1991EP0451431A1 Pharmaceutical composition
10/16/1991EP0451299A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
10/16/1991EP0451156A1 Minoxidil and vasoconstrictor compositions for treating alopecia
10/16/1991EP0277151B1 Novel medicinal use of nucleosides
10/16/1991EP0229810B1 Protection of proteins and the like
10/16/1991EP0191867B1 Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
10/16/1991CN1055365A Haloethyl-substituted steroidal enzyme inhibitors
10/16/1991CN1055364A Sulfonylphenyl-beta-d-thioxylosides, their method of preparation and their use in therapeutics
10/16/1991CN1055363A Process for preparing derivatives of 1-dethia 2-thia cephalosporanic acid
10/16/1991CN1055362A Hydroxymethyl-indolizidines and quinolizidines
10/16/1991CN1055361A Substituted pyrrole, process for preparing same, preparation containing compounds, and use
10/16/1991CN1055355A Stablizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method therefor and drug stabilized thereby
10/16/1991CN1014323B Method for extracting physiological active substances from pine-nut shell
10/16/1991CN1014322B Technique for extracting polysaccharide from root of bidentate achyranthes
10/15/1991US5057614 Substituted pyrroles
1 ... 7318 7319 7320 7321 7322 7323 7324 7325 7326 7327 7328 7329 7330 7331 7332 7333 7334 7335 7336 7337 7338 ... 7860